Suppression of ErbB-2 in androgen-independent human prostate cancer cells enhances cytotoxic effect by gemcitabine in an androgen-reduced environment

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (2R01 CA88184, PC050769, PC074289)
  • U.S. Department of War (2R01 CA88184, PC050769, PC074289)

This publication has 41 references indexed in Scilit: